High lactate dehydrogenase levels at admission for painful vaso-occlusive crisis is associated with severe outcome in adult SCD patients

Clinical Biochemistry

Volumn 45, Issue 18, 2012, Pages 1578-1582

  Stankovic Stojanovic, Katia ^a   Steichen, Olivier ^a,b   Lefevre, Guillaume ^a   Bachmeyer, Claude ^a   Avellino, Virginie ^a   Grateau, Gilles ^a,b   Girot, Robert ^a,b   Lionnet, François ^a  

^a HÔPITAL TENON   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

Acute chest syndrome; Fever; Lactate dehydrogenase; Procalcitonin; Prognosis; Sickle cell disease

Indexed keywords

LACTATE DEHYDROGENASE; PROCALCITONIN;

ACUTE CHEST SYNDROME; ADULT; ARTICLE; DISEASE SEVERITY; FEMALE; HEALTH STATUS; HETEROZYGOTE; HOMOZYGOTE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OCCLUSION; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SICKLE CELL ANEMIA; VASOOCCLUSIVE CRISIS;

ADULT; ANEMIA, SICKLE CELL; CARDIOVASCULAR DISEASES; FEMALE; HOSPITALIZATION; HUMANS; L-LACTATE DEHYDROGENASE; MALE; PAIN; PROGNOSIS; YOUNG ADULT;

EID: 84870686704     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2012.07.114     Document Type: Article

References (17)

1. Rees D.C., Gibson J.S. Biomarkers in sickle cell disease. Br J Haematol 2012, 156:433-445.
2. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655.
3. Wanko S.O., Telen M.J. Transfusion management in sickle cell disease. Hematol Oncol Clin North Am 2005, 19:803-826.
4. National Heart, Lung, and Blood Institute, Division of blood diseases and resources. The management of sickle cell disease. NIH publication n°02-2117, revised June 2002 (4rth edition).
5. Lionnet F., Arlet J.B., Bartolucci P., Habibi A., Ribeil J.A., Stankovic K. Guidelines for management of adult sickle cell disease. Rev Med Interne 2009, 30(Suppl. 3):S162-S223.
6. Coste J., Pouchot J. A grey zone for quantitative diagnostic and screening tests. Int J Epidemiol 2003, 32:304-313.
7. Jensen J.U., Heslet L., Jensen T.H., Espersen K., Steffensen P., Tvede M. Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 2006, 34:2596-2602.
8. Sponholz C., Sakr Y., Reinhart K., Brunkhorst F. Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature. Crit Care 2006, 10:R145.
9. Christ-Crain M., Müller B. Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators. Eur Respir J 2007, 30:556-573.
10. Stankovic Stojanovic K., Steichen O., Lionnet F., Bachmeyer C., Lecomte I., Avellino V., et al. Is procalcitonin a marker of invasive bacterial infection in acute sickle-cell vaso-occlusive crisis?. Infection 2011, 39:41-45.
11. Booth C., Inusa B., Obaro S.K. Infection in sickle cell disease: a review. Int J Infect Dis 2010, 14:e2-e12.
12. Quinn C.T., Lee N.J., Shull E.P., Ahmad N., Rogers Z.R., Buchanan G.R. Prediction of adverse outcomes in children with sickle cell anemia: a study of the Dallas newborn cohort. Blood 2008, 111:544-548.
13. Olatunji P.O., Davies S.C. The predictive value of white blood cell count in assessing clinical severity of sickle cell anaemia in Afro-Caribbeans patients. Afr J Med Med Sci 2000, 29:27-30.
14. Litos M., Sarris I., Bewley S., Seed P., Okpala I., Oteng-Ntim E. White blood cell count as a predictor of the severity of sickle cell disease during pregnancy. Eur J Obstet Gynecol Reprod Biol 2007, 133:169-172.
15. Okpala I. Leukocyte adhesion and the pathophysiology of sickle cell disease. Curr Opin Hematol 2006, 13:40-44.
16. Taylor J.G., Nolan V.G., Mendelsohn L., Kato G.J., Gladwin M.T., Steinberg M.H. Chronic hyper-hemolysis in sickle cell anemia: association of vascular complications and mortality with less frequent vasoocclusive pain. PLoS One 2008, 3:e2095.
17. Kato G.J., McGowan V., Machado R.F., Little J.A., Taylor J., Morris C.R., et al. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood 2006, 107:2279-2285.